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When human cells sustain a DNA double-strand break (dsb), histone H2AX in chromatin surrounding the DNA break
is phosphorylated, marking repair foci. The number of phosphorylated histone H2AX (cH2AX) foci approximates the
number of dsb present in the cell’s nuclear DNA. We observed 0.4 cH2AX foci per nucleus in primary human
melanocytes. In contrast, in four melanoma cell lines, we detected 7–17 cH2AX foci per nucleus, a 17–42 times
increase in the basal level of cH2AX foci in melanoma cells relative to melanocytes (MC). Thus, untreated melanoma
cells express significantly greater numbers of cH2AX foci than do untreated MC. Detection and rejoining of ionizing
radiation-induced DNA dsb proceeded as rapidly in melanoma cells as in MC. Melanoma cells, however, reduced
the number of radiation-induced cH2AX foci down only to pre-irradiation levels. Co-localization of the majority of
cH2AX foci with ataxia telangiectasia mutated, BRCA1, 53BP1, and Nbs1 foci in untreated melanoma cells indicated
that the additional foci in melanoma cells were associated with a DNA change that the cells interpret as DNA dsb.
Co-localization of cH2AX foci with the telomere replication factor 1 protein in untreated melanoma cells indicates
that the additional foci in untreated melanoma cells are associated with dysfunctional telomeres that induce a DNA
damage stress response.
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The skin is the primary barrier for humans against the ex-
ternal environment. Thus, skin cells are frequently the first
cells to be exposed to physical and chemical genotoxic
agents such as ultraviolet (UV) and ionizing radiations (IR).
Exposure to UV radiation is considered to be the major
contributing factor to melanomagenesis (Jhappan et al,
2003), although the molecular pathway(s) leading from UV-
induced DNA photoproducts to melanoma is as yet unclear.
Melanoma develops through well-defined morphological
and histological stages that involve the loss of control of cell
proliferation, acquisition of invasiveness, and ultimately ac-
quisition of metastatic potential (Clark et al, 1984). The nor-
mal melanocytic cell, presumably damaged in its genome
by sun exposure, develops through primary melanoma
in situ and ultimately to metastatic melanoma. From its ear-
liest stages, melanomagenesis involves elevated frequen-
cies of mutations and/or loss of tumor suppressors and
oncogenes (Albino et al, 1997; Hussein and Wood, 2002),
microsatellite instability (Hussein and Wood, 2002), an-
euploidy detected with increases in the DNA content (Pilch
et al, 2000; Runger et al, 2003), and an increase in the fre-
quency of micronuclei (Runger et al, 2003).
The chromosome rearrangements observed in me-
lanoma cells likely require naturally or environmentally in-
duced DNA double-strand breaks (dsb) as intermediates.
The presence of DNA dsb in the cell genome induces for-
mation of repair foci (Petrini and Stracker, 2003). So one
approach to assess the involvement of DNA dsb in chro-
mosome instability is to evaluate the expression of dsb-
induced repair foci in melanoma cells. Nuclear phosphati-
dylinositol 3–OH serine/threonine protein kinase-like kin-
ases (PIKK) recognize the presence of DNA dsb in the cell
DNA, and transduce this fact via phosphorylations to down-
stream effector proteins that participate in DNA dsb repair
processes. One type of DNA dsb repair focus involves
phosphorylated H2AX (gH2AX) histone proteins (Sedelnik-
ova et al, 2002; Rothkamm and Lobrich, 2003). Production
of DNA dsb in nuclear DNA induces phosphorylation of the
H2AX histone at serine 139, which is in an evolutionarily
conserved PIKK motif (Rogakou et al, 1998, 2000; Burma
et al, 2001). Two nuclear PIKK, the ataxia telangiectasia
mutated (ATM) and DNA-dependent protein kinase (DNA
PK) protein kinases, have been shown to phosphorylate hi-
stone H2AX in response to IR forming nuclear foci (Burma
et al, 2001; Bakkenist and Kastan, 2003; Park et al, 2003;
Stiff et al, 2004). As the ATM and DNA PK kinases phos-
phorylate the H2AX protein in chromatin adjacent to a DNA
dsb, the locally high concentration of gH2AX protein can be
detected by immunofluorescence as foci (Rogakou et al,
1999; Rothkamm and Lobrich, 2003). In addition to trauma-
induced DNA dsb, phosphorylated H2AX histone foci have
been detected in S-phase cells (Mirzoeva and Petrini, 2003)
and at uncapped telomeres (Takai et al, 2003). There is a
close correlation between the number of DNA dsb and the
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number of Type II nuclear gH2AX foci induced by IR (Se-
delnikova et al, 2002; Rothkamm and Lobrich, 2003). There-
fore, the number of gH2AX foci has been taken to indicate
the number of DNA dsb in the cell’s nuclear DNA (Sedelnik-
ova et al, 2002; Rothkamm and Lobrich, 2003).
In a recent study of the expression of phosphorylated
H2AX histone in cultured primary skin cells and their can-
cers, we found that untreated cancer cells expressed sig-
nificantly higher levels of gH2AX foci than did primary skin
cells. These phenomenological observations suggested
that some characteristics of skin cancer cells result in high-
er basal levels of DNA repair foci. As some chromosome
rearrangements require DNA dsb as an intermediate, and
melanoma cells generally express chromosome instability
during their development, we speculated that the high basal
levels of gH2AX foci might reflect high levels of chromo-
some instability in these cancer cells. In this report we have
examined the relationship between the expression of DNA
gH2AX foci and the expression of chromosome instability
(i.e., micronuclei) in melanocytes (MC) and melanoma cells.
Results
Phosphorylated H2AX histone foci are detected in un-
treated MC and melanoma cells We recently examined
cultured primary MC and melanoma cells by indirect
immunofluorescence for the expression of gH2AX foci.
gH2AX foci with a diameter of 0.25–1.0 mm were observed.
The number of gH2AX foci observed in untreated MC was
low (Fig 1A). The distribution of foci counted per nucleus in
untreated MC was skewed toward cells containing less than
5 foci per nucleus. Ninety percent of MC contained 1 or no
foci (Fig 2A). On an average 0.4, 0.8, and 2.0 gH2AX foci
were detected per nucleus in untreated MC, fibroblasts
(FB), and keratinocytes, respectively (Table I). This is within
the range of values, from 0.05 to 1.5 foci per nucleus, re-
ported in the literature for primary human FB (Rogakou et al,
1999; Rothkamm and Lobrich, 2003). In contrast, greater
numbers of gH2AX foci were detected in the nuclei of un-
treated melanoma and carcinoma cells (Fig 1C and Table I).
The distribution of gH2AX foci counted per untreated
YUSAC2 nucleus was skewed toward 15–25 foci per nucle-
us (Fig 2A) with an average of 17 foci per cell nucleus (Table
I). A shift toward higher numbers of foci/nucleus was also
observed in the other melanomas examined (Fig 2C). Sev-
enty-five percent of YUSIT1 cells contained 3 or more foci,
whereas 76% of YUSAC2 cells contained 6 or more foci per
nucleus. Detecting larger numbers of gH2AX foci in me-
lanoma cells was not surprising because cancer cells have
been reported to express higher numbers of gH2AX foci. For
instance, about 2.5 foci per nucleus were reported to occur
in a human astrocytoma and a fibrosarcoma (Rogakou et al,
1999; Sedelnikova et al, 2002). A range of gH2AX foci yields
was also observed in untreated cells from other cancers.
For instance, we observe 5.2 foci per HeLa S3 cell nucleus
and 13.7 foci per HaCat cell nucleus (Table I). Our results
indicated that untreated melanoma and carcinoma cells
contain significantly higher numbers of gH2AX foci, and thus
presumably DNA dsb, than do untreated primary MC.
DNA dsb detection in MC and melanoma cells A direct
relationship between the number of DNA dsb induced by IR
and the number of gH2AX foci has been reported (Se-
delnikova et al, 2002; Rothkamm and Lobrich, 2003), indi-
cating that the number of gH2AX foci detected in cell nuclei
reflects the number of DNA dsb. When the length of double-
stranded DNA prepared from untreated MC, YUSIT1, or
YUSAC2 cells was compared on the type of pulsed field
agarose gels that resolve Schizosaccharomyces pombe
chromosomal DNA (Warters, 1992; Warters and Lyons,
1992), no consistent difference was detected between any
of the three cell types (results not shown). But as the
number of DNA dsb expected in melanoma cell DNA (i.e.,
about 17–20) is comparable to a radiation dose of about
0.5 Gy, and as this dose is below the resolution of this ag-
arose gel approach (Warters and Lyons, 1992; Rothkamm
and Lobrich, 2003), it is not surprising that we could not
detect higher numbers of dsb in the melanoma cells than in
MC by physical chemical methods.
To demonstrate that in our hands the gH2AX immuno-
fluorescence approach actually detects DNA dsb, we com-
pared the expression of gH2AX foci at various times after
cells were exposed either to H2O2 or to g radiation. H2O2
produces few DNA dsb. In contrast, IR is an efficient in-
ducer of DNA dsb. Few additional gH2AX foci were induced
over the background level for up to 4 h after cells were
exposed to 20 mM H2O2 for 15 min at 41C (results not
shown). Significantly greater numbers of foci were detected
when MC (Fig 1B) or YUSAC2 cells (Fig 1D) were collected
and analyzed at various times after irradiation. The number
of gH2AX foci expressed, as a function of time after
Figure1
Detection of cH2AX foci in primary melanocytes (MC) and me-
lanoma cells. Primary neonatal MC (Panels A and B) or YUSAC2 me-
lanoma cells (Panels C and D) were grown on serum-coated cover slips
and either exposed to 1.5 Gy of g radiation (Panels B and D) or left
unirradiated (Panels A and C). Cover slips were collected 60 min after
treatment, the cells were fixed with formaldehyde, and analyzed for the
presence of gH2AX in their nuclei by indirect immunofluorescence, as
described above.
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irradiation, should indicate the efficiency at which MC or
YUSAC2 cells recognize and respond to DNA dsb, and the
efficiency with which those DNA dsb are rejoined (Rot-
hkamm and Lobrich, 2003). As shown in Fig 3A, the number
of gH2AX foci detected as a function of incubation time after
exposure to 1.5 Gy increased to a maximum by 30–60 min,
declined between 1 and 6 h with a half-time of about 3–4 h,
and became essentially constant in both cell types by 8–12
h. There were two major differences in expression of gH2AX
foci between the two cell types. The basal number of nu-
clear foci began at a higher number in YUSAC2 cells than in
MC, and the number of residual gH2AX foci 12 h after ir-
radiation approached the pretreatment number of foci in
YUSAC2 cells, not the lower number observed in MC (Fig
3A). Sixty minutes after exposure to 1.5 Gy, the number of
IR-induced foci redistributed to 25–30 in MC and 45–50 in
YUSAC2 cells (Fig 2B). The total number of repair foci in-
duced per Gy of IR (total nuclear foci in irradiated minus
untreated cells) at all radiation doses was the same, or less,
in YUSAC2 cells than in MC (Fig 3B). IR induced 21 and 16
foci per nucleus per Gy, respectively, in MC and YUSAC2
cells (Table I). This is about half the yield of foci or DNA dsb
reported previously to occur in irradiated cells (Rothkamm
and Lobrich, 2003). Our results indicate that whereas we
may underestimate the number of foci in untreated or irra-
diated cells, expression of gH2AX foci detects IR-induced
DNA dsb. The efficiency at which MC and YUSAC2 cells
detect IR-induced DNA dsb and phosphorylate the H2AX
Figure 2
Distribution of cH2AX foci in untreated
or irradiated melanocytes (MC) and
YUSAC2 cells. MC (open bars) or YU-
SAC2 (closed bars) cells growing on se-
rum-coated cover slips were left
untreated (Panel A) or exposed to 1.5 Gy
ionizing radiation (Panel B), collected at
60 min, and stained with an antibody
against the gH2AX protein. Alternatively,
untreated YUGEN8, LOX, and YUSIT1
cells were similarly collected and stained
(Panel C). Cells were imaged by immuno-
fluorescence microscopy and the number
of gH2AX foci in more than 40 total cells
per group counted. The fraction of cells
counted that express the indicated num-
bers of repair foci is plotted.
Table I. Yield of radiation-induced cH2AX foci
cH2AX foci/nucleusa
Fraction Sb MN/1000 cellsc DId0 Gy 1 Gy Net change
MC 0.4  1.5 21  6 20 0.23 9 1.0
FB 0.8  1.9 27  10 26 0.15 15 1.1
KC 2.0  3.5 31  9 29 ND 45 ND
HeLa 5.2  4.4 ND ND 0.41 179 1.6
YUSIT 6.5  7.3 32  12 26 0.26 478 1.8
YUGEN 10  13 33  13 24 0.41 476 1.7
LOX 11  11 28  11 18 0.40 32 1.6
HaCaT 14  10 ND ND 0.47 57 1.5
YUSAC 17  412 32  8 16 0.43 218 1.7
aProliferating primary melanocytes (MC), fibroblasts (FB), or keratinocytes (KC); YUSIT1, YUSAC2, YUGEN8, or LOX melanoma cells, and HeLa or
HaCaT carcinoma cells growing on glass cover slips, were exposed to 1 Gy of g rays, or left untreated, and collected at 60 min. The cells were fixed with
formaldehyde 60 min after treatment, exposed to a primary antibody to gH2AX and subsequently to a secondary antibody conjugated to the Alexa 488
fluorescent dye.Images (similar to Fig 1) were quantified using a fluorescence microscope and the results in one representative experiment out of at least
two repeat experiments are expressed as the total number of gH2AX foci detected per nucleus (average  1 SD). The net change is the total number of
foci in irradiated minus the total number of foci in untreated cells.
bThe average fraction of untreated cells found to be in the S phase of the cell cycle in two to four repeats was determined by flow cytometry.
cUntreated cells were exposed to 3 mg per mL Cytochalasin B for 48 h. Cells on coverslips were collected, stained with diamidinophenyl indole and the
number of micronuclei in X1000 total binucleated cells determined. Data are expressed as the total number of micronuclei per 1000 binucleated cells.
dThe untreated cell DNA index (DI) is expressed as the ratio of the G1 DNA content in test cells/the G1 DNA content in MC, as described in the
Materials and Methods section.
ND, not determined.
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protein, the expression kinetics of repair foci as a function of
time after exposure to IR, and the residual number of foci
remaining in cell nuclei 12 h after irradiation are the same in
both cell types. Thus, both MC and YUSAC2 cells recognize
IR-induced DNA dsb and articulate this into repair foci with
similar efficiencies.
cH2AX foci in untreated cells co-localize with DNA repair
complex proteins Our results (Fig 3B and Table I) indicate
that in all irradiated cells, PIKK, such as the ATM protein,
recognize IR-induced DNA dsb, are activated, and phos-
phorylate the H2AX histone to an equivalent extent. As the
number of foci remaining in previously irradiated YUSAC2
cells is the same as the number of foci that existed prior to
irradiation (Fig 3A), the repair process that rejoins IR-in-
duced DNA dsb appears not to act on the DNA changes
that existed prior to irradiation. Thus, this pre-existing DNA
damage must be qualitatively different from IR-induced
DNA dsb. To examine the similarity of this pre-existing DNA
damage with IR-induced dsb, untreated or irradiated cells
were exposed simultaneously to antibodies against gH2AX
and other proteins that localize to induced DNA dsb. An-
tibodies to the ATM protein phosphorylated on serine 1981,
to 53BP1 protein phosphorylated on serine 25 and to the
BRCA1 protein formed foci in irradiated, as well as untreat-
ed, melanoma cells, and co-localized with gH2AX foci. Ap-
proximately 80%–90% of gH2AX foci co-localized with
either the 53BP1, the BRCA1, or the phosphorylated ATM
protein foci observed in untreated, as well as in irradiated,
primary and melanoma cells (Fig 4). As the BRCA1 and
phosphorylated form of the 53BP1 protein forms foci at
DNA dsb (Celeste et al, 2003), these results are consistent
with the gH2AX foci detected in melanoma cells being as-
sociated either with DNA dsb or with some change in nu-
clear chromatin that is recognized as a DNA dsb.
Foci of the Nbs1 protein were formed, and co-localized
with gH2AX foci, in MC and melanoma cells that were ex-
posed to 100 cGy and collected 1 h after irradiation (results
not shown). The Nbs1 also formed foci in untreated MC or
melanoma cells (Fig 4). Approximately 80%–90% of the
gH2AX foci observed in untreated YUSIT1 or YUSAC2 cells
co-localized with Nbs1 protein foci. As the Nbs1 protein
associates into multi-protein repair complexes at DNA dsb
(Furuta et al, 2003), the results indicate that the gH2AX foci
detected in untreated melanoma cells are present at chro-
matin sites and are associated with active DNA dsb repair
complexes.
Figure 3
Expression of cH2AX repair foci in irradiated melanocytes (MC).
(Panel A) Appearance and disappearance of ionizing radiation- (IR-)
induced gH2AX foci in MC and YUSAC2 cells. MC (open symbols) or
YUSAC2 cells (closed symbols) were exposed to 1.5 Gy of g irradiation,
replaced at 371C, and collected at increasing times, as indicated. The
number of gH2AX foci per cell nucleus was quantified at each time
point and plotted (Av  1 SD). (Panel B) Concentration dependence for
the expression of IR induced repair foci. MC or YUSAC2 cells were
exposed to increasing g ray doses, replaced at 371C for 60 min, and the
number of gH2AX foci/nucleus quantified as described above.
Figure4
cH2AX foci co-localize with other double-strand break-associated
proteins in untreated melanoma cells Untreated YUSAC2 (Panels
A–D) or melanocytes (MC) (Panel E) were collected and exposed to
primary antibodies against gH2AX and either 53BP1 (Panel A), BRCA1
(Panel B), Nbs1 (Panel C), or telomere replication factor 1 (TRF1) (Pan-
els D and E). Cells were exposed to an Alexa 488-conjugated second-
ary antibody (green fluorescence) to gH2AX and an Alexa 568-
conjugated secondary antibody to all other primary antibodies. Cells
were imaged with a fluorescence microscope as described in Methods.
Results very similar to YUSAC2 cells were obtained with YUSIT1 cells.
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Untreated melanoma cells contain few apoptotic
cells One possible explanation for the elevated numbers
of gH2AX foci observed in untreated melanoma cells might
be that there is a high basal level of apoptosis in melanoma
cells. The magnitude of sub-diploid DNA in untreated MC,
LOX, YUSIT, YUGEN, and YUSAC cells, determined by flow
cytometry was 2.6%, 1.0%, 2.0%, 2.3%, and 4.3%, re-
spectively, of the total cell population. Only YUSAC2 me-
lanoma cells contained a sub-diploid DNA content greater
than MC. Thus, melanoma cells contain low basal levels of
apoptotic cells. Less than 1% of the cells in any of the
melanomas had a nuclear morphology (i.e., perinuclear
condensed chromatin or fragmented nuclei) consistent with
cells that are in the process of apoptosis (Wyllie et al, 1980).
Thus, the fraction of apoptosing melanoma cells is probably
too small to significantly alter the number of foci counted in
untreated melanoma cell lines. To further reduce this pos-
sibility, cells with abnormal nuclear morphologies were ex-
cluded from our results.
Cell cycle analysis Greater H2AX histone protein phos-
phorylation has been reported in the S phase of the cell cycle
of untreated cells (Furuta et al, 2003; MacPhail et al, 2003;
Mirzoeva and Petrini, 2003). Thus, another explanation for
the higher frequency of foci in melanoma cells might be that
cancer cells contain a higher fraction of proliferating cells and
thus a higher fraction of S-phase cells than do MC. When the
fraction of cells in the S phase of the cell cycle was deter-
mined by flow cytometry (Table I), increases in gH2AX foci
generally correlated with increases in the fraction of S-phase
cells. But whereas 30%–40% of melanoma cells are in the S
phase of the cell cycle, the majority of melanoma cells (70%–
80%) contain elevated levels of H2AX foci. Thus, it is unlikely
that all gH2AX foci occur in S-phase cells.
To examine gH2AX expression throughout the cell cycle,
untreated MC and melanoma cells were stained with prop-
idium iodide for DNA content and with an antibody for
phosphorylated H2AX, and analyzed by flow cytometry
(Fig 5). All cell types examined, including MC, FB, YUSIT1,
YUSAC2, and HaCaT, gave a qualitatively similar distribu-
tion of gH2AX fluorescence throughout the cell cycle. All cell
cycle phases in all cells examined expressed at least some
fluorescence, with total fluorescence in S and G2\M phases
being approximately two to three times greater than in G1-
phase cells. Total fluorescence throughout the cell cycle of
YUSIT1 cells (Fig 5), as well as YUSAC2 cells (results not
shown), was approximately 4–5-fold greater than observed
in similar cell-cycle phases of MC. Thus, higher fractions of
S phase and proliferating cells in melanomas cannot explain
fully the increase in gH2AX foci in melanomas.
cH2AX foci co-localize with a telomere-associated pro-
tein in untreated melanoma cells A possible explanation
for the elevated gH2AX foci in untreated melanoma cells
might be that these cancer cells have aberrant telomere
replication and/or aberrant telomere structure (Fagogna
et al, 2003; Takai et al, 2003). To examine this possibility, we
examined MC and melanoma cells for expression of gH2AX
and telomere replication factor 1 (TRF1) (Fig 4). The TRF1
protein decorates nuclear telomeric DNA sequences and
can be detected as foci in interphase cells (Chong et al,
1995; Shen et al, 1997). A large number of TRF1 foci, about
30–50, appeared to be present in MC, FB, and melanoma
cells, but were too numerous to count (Fig 4). Additionally,
there was about 1.5 to two times more TRF1 protein flu-
orescence from melanomas than from primary skin cells.
Approximately, 50% of gH2AX foci in untreated MC and FB
co-localized with TRF1 foci, whereas 60% or more of the
gH2AX foci in untreated YUSIT1 or YUSAC2 cells co-local-
ized with TRF1 foci (Fig 4). Thus, the majority of gH2AX foci
observed in untreated MC or melanoma cells co-localize
with foci of the TRF1 protein and thus likely co-localize with
telomeric DNA sequences.
Figure 5
Flow cytometric analysis of cH2AX flu-
orescence throughout the cell cycle of
melanocytes (MC) and YUSIT1 cells. MC
(Panels A and C) or YUSIT1 cells (Panels B
and D) were exposed either to a nonspe-
cific immunoglobulin G1 (IgG1) protein
(Panels A and B) or with the anti-gH2AX
monoclonal antibody (Panels B and D).
The cells were stained with an Alexa 488-
conjugated, anti-mouse secondary anti-
body, their DNA stained with propidium
iodide, and the cells analyzed by flow
cytometry as described in Methods. The x-
axis in arbitrary units represents increasing
red (PI) fluorescence, the y-axis in arbitrary
units represents increasing green (Alexa
488) fluorescence, and the z-axis repre-
sents the number of events (number of
cells analyzed). Results are a representa-
tive experiment from two or more repeats.
G1 cells (at left of each panel) express
lower red and green fluorescence relative
to S and G2/M cells.
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Melanoma cells contain greater numbers of micronu-
clei Another approach to evaluate the number of DNA dsb
occurring in untreated melanoma cells is to determine the
occurrence of micronuclei in these cells. Micronuclei result
from acentric chromosome fragments, requiring the pres-
ence of either one (i.e., deletion-type aberrations) or two
(i.e., exchange-type aberrations) dsb per micronucleus. The
detection of additional micronuclei in melanoma cells rela-
tive to MC would indicate the presence of excess DNA dsb
in melanoma cells. When MC or melanoma cells were as-
sessed for the presence of micronuclei (Fig 6), on an av-
erage 0.4%, 28.6%, 26.3%, 2.9%, and 20.6%, respectively,
of MC, YUSIT1, YUGEN8, LOX, and YUSAC2 cells con-
tained one or more micronuclei. Expressed as the number
of micronuclei observed per 1000 cells, all melanoma cells
contained significantly greater numbers of micronuclei than
did MC (Table I), with some individual melanoma cells ex-
pressing as many as five micronuclei. With the exception of
the LOX cells, untreated melanoma cells containing high
numbers of gH2AX foci also expressed high numbers of
micronuclei. Thus, whereas the correlation between the
number of gH2AX foci and the number of micronuclei in
melanoma cells is not a direct one, the results are consist-
ent with untreated melanoma cells generally containing
greater numbers of micronuclei, and thus DNA dsb, than
do MC.
DNA index is higher in melanoma cells A DNA index (DI)
was determined by flow cytometry for all melanoma cell
lines (Table I). The DI was calculated as the G1 DNA content
of melanoma cells divided by the G1 DNA content of primary
MC. Passage 7 primary human FB were included as an
internal standard and had a DI of 1.06 relative to primary
MC. All melanoma cells exhibited a DI of between 1.6 and
1.8, consistent with significant increase in ploidy in all the
melanoma cell lines examined. Although these results indi-
cated significant changes in the DNA content of the me-
lanoma cells, there was no direct correlation between the DI
(aneuploidy) and either the number of gH2AX foci per un-
treated nucleus or the number of micronuclei per 1000 total
cells.
The DNA dsb-induced stress response is defective in
melanoma cells Higher basal levels of DNA dsb in me-
lanoma cells might result from a failure of stress-signaling
pathways to recognize DNA dsb and articulate this recog-
nition to DNA damage removal processes. To assess this
possibility, we examined the integrity of the p53 DNA dam-
age response pathway in MC and melanoma cells. The ba-
sal level of p53 protein was similar in untreated MC and
YUSAC2 cells, but was significantly elevated, relative to
MC, in untreated LOX, YUSIT1, and YUGEN8 cells (Fig 7
and Table II). Using indirect immunofluorescence, we found
that the p53 protein in both MC and the YUSAC2 cells was
expressed exclusively as a nuclear epitope (results not
shown). Elevated basal levels of p53 indicate that the cell’s
ability to regulate p53 protein levels through transcription or
proteolysis is disrupted in LOX, YUSIT1, and YUGEN 8
cells, likely because of mutations in the p53 protein.
The activity of the PIKK-directed, DNA damage response
pathway was also assessed. When cells are exposed to IR,
the induced DNA dsb are recognized by PIKK such as the
ATM protein, which subsequently phosphorylates down-
stream target proteins (Kastan and Lim, 2000; Bradbury and
Jackson, 2003). As the level of IR-induced H2AX histone
phosphorylation is the same in all cells examined (Table I),
IR-induced activation of the ATM and DNA PK proteins must
be intact and equivalent in all five cell types. Another ATM
protein target is the Chk2 protein (Chehab et al, 2000;
Matsuoka et al, 2000), which subsequently phosphorylates
serine 20 of the p53 protein (Chehab et al, 1999; Shieh et al,
1999; Hirao et al, 2000). Phosphorylation of p53 at serine 20
inhibits hMDM2 ubiquitination of the p53 protein (Shieh
et al, 1997; Siliciano et al, 1997), inhibits p53 degradation by
the 26S proteasome (Haupt et al, 1997; Kubbutat et al,
Figure6
Micronuclei in melanocytes (MC) and YUGEN8 cells. Untreated MC
(Panel A) or YUGEN8 (Panel B) cells were exposed to Cytochalasin B
for 48 h as described in Methods. Cells were stained with diamidino-
phenyl indole (DAPI) and visualized with a fluorescent microscope.
Small DAPI stained, extranuclear particles were counted as micronu-
clei.
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1997), and results in an increase in both the half-life and
total cellular content of the p53 protein. IR exposure in-
creased the cellular level of p53 protein in MC, LOX, and
YUSAC2 cells (Fig 7 and Table II). Thus, only in MC, LOX,
and YUSAC2 cells is the IR-induced pathway intact, result-
ing in an increase in the half-life of the p53 protein.
Another down-stream target of activated ATM and DNA
PK proteins is p53 serine 15 phosphorylation (Banin et al,
1998; Canman et al, 1998). Phosphorylation of p53 serine
15 plays a role in activation of the p53 protein as a tran-
scription factor (Lambert et al, 1998). Relative to the re-
sponse in MC, p53 serine 15 was phosphorylated
significantly only in irradiated YUSIT1 and YUSAC2 cells
(Fig 7 and Table II), indicating that although the ATM and
DNA PK are functional and activated in all four irradiated
melanoma cell lines, they phosphorylate the p53 serine 15
at significant levels only in MC, YUSIT1, and YUSAC2 cells.
When p53 is activated as a transcription factor, target genes
such as the CDKN1Ap21/Waf1 gene are transcribed, inducing
increases in CDKN1A protein levels. After irradiation,
CDKN1A protein levels relative to untreated MC increased
significantly only in MC and LOX cells, whereas they de-
clined relative to MC in all other melanoma cell lines (Table
II). Thus, the DNA dsb response pathway that is mediated
through the p53 protein appears to be intact and fully func-
tional only in primary MC. As the ATM and DNA PK proteins
appear to be fully functional, it is likely that this DNA dsb
response pathway is disrupted in melanoma cells by mu-
tations in the p53 protein.
Discussion
The transition from MC expressing strict growth control to a
proliferating melanoma cell involves a number of biochem-
ical and biological steps (Clark et al, 1984; Albino et al,
1997). Loss of control of genome stability is generally con-
sidered to be a central aspect of any carcinogenesis proc-
ess (Lengauer et al, 1998; Coleman and Tsongalis, 1999).
This is the case for melanomagenesis in which melanoma
cells express genome instability early on during melanoma
development (Albino et al, 1997). One type of genome in-
stability that occurs early during melanomagenesis is chro-
mosome instability (Bastian, 2003). Chromosome instability
is detectable in mitotic cells as chromosome rearrange-
ments, and is detectable in interphase cells as aneuploidy
and/or the presence of micronuclei (Pilch et al, 2000; Rung-
er et al, 2003).
In this work, we speculated that chromosome instability
in melanoma cells results from increases in DNA dsb, and
that these dsb would be detected as phosphorylated hi-
stone H2AX foci. Structural changes that occur in chromatin
surrounding DNA dsb are recognized by the ATM protein
(Bakkenist and Kastan, 2003), which phosphorylates the
H2AX histone protein in chromatin adjacent to DNA dsb.
These high local concentrations of phosphorylated histone
H2AX are detected as foci of fluorescence (Rogakou et al,
1999; Burma et al, 2001; Rothkamm and Lobrich, 2003)
(Fig 1). Thus, if chromosome instability in melanoma cells
results from high frequencies of DNA dsb, this should be
detected as increases in the number of nuclear gH2AX foci.
All melanoma cells examined in this report expressed levels
of gH2AX foci, as well as chromosome structural and nu-
merical instabilities such as micronuclei and aneuploidy,
significantly higher than in primary MC (Table I). We did not,
Table II. Relative level of stress responses in melanoma cellsa
Relative p53b p53c p53S15pd CDKN1Ad
0 Gy 2 Gyþ1 H 2 Gyþ 1 H 2 Gyþ4 H
MC 1.0 4.1 342 8.0
YUSIT1 13.4 0.7 116 0.3
YUGEN8 24.2 0.9 15 0.3
LOX 4.1 1.7 16 3.6
YUSAC2 0.7 3.1 142 0.3
aProliferating melanocytes (MC), YUSIT1, YUGEN 8, LOX, or YUSAC2 melanoma cells were left untreated (Relative p53) or exposed to 2 Gy of g rays
and collected at 1 (p53 or p53s15p) or 4 (CDKN1A) hours. Protein was collected from irradiated or untreated cells, electrophoresed through gels,
transferred to membranes and analyzed by western analysis either for the p53 protein (p53), p53 phosphoserine 15 (p53s15p) or CDKN1A protein.
bResults are expressed as the ratio of total p53 protein detected in untreated melanoma cells relative to total p53 protein in untreated MC, which is set
at 1.0.
cCells were exposed to 2 Gy and collected at 1 h. Results are expressed as the ratio of the total p53 signal detected in treated cells divided by the total
signal detected in untreated cells within each cell type.
dCells were exposed to 2 Gy and collected either at 1 (p53 or p53s15p) or 4 h (CDKN1A). Results are expressed as a ratio of the total epitope signal
detected in treated cells divided by the total signal detected in untreated MC.Table II results are the average of two repeats.
Figure 7
Western analysis of the TP53 DNA damage response pathway in
cultured melanocytes (MC) and melanoma cells. MC, YUSAC2, or
YUSIT1 cells were exposed to 2 Gy, or left untreated, and replaced at
371C for 1 or 4 h, as indicated. At these times, cell protein was recov-
ered, separated through PAGE gels, transferred to a membrane, and
analyzed by western analysis for the epitopes indicated to the right.
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however, observe a consistent correlation between in-
creased numbers of gH2AX foci and increased numbers of
micronuclei in the same untreated melanoma cells (Table I).
In fact, the relationship was reversed in two carcinoma cell
lines (Table I). Thus, whereas both gH2AX foci and micro-
nuclei are consistently elevated in melanomas, our results
are not consistent with there being a direct relationship be-
tween the formation of gH2AX foci and the production of
micronuclei in untreated melanoma cells.
It remains an interesting question as to why there is such
a large increase in the number of gH2AX foci in untreated
melanoma cells. Our flow cytometric (FCM) analysis indi-
cates that at least a portion of the increased gH2AX fluo-
rescence in untreated melanoma cells may be explained by
an increase, relative to MC cells, in the fraction of melanoma
cells that are proliferating. Thus, a portion of the increase in
gH2AX foci may be explained by an increase in the propor-
tion of S-phase cells, and thus DNA replication-associated
DNA strand breaks, in untreated melanoma cells (Furuta
et al, 2003). The fraction of melanoma cells in the S phase of
the cell cycle is about 2-fold higher than in MC (Table I), and
the total gH2AX fluorescence in S- and G2/M-phase cells is
approximately 2-fold greater than that observed in G1-
phase cells (Fig 5). Thus, increased melanoma cell prolif-
eration may explain a portion, but not all, of the increase in
gH2AX fluorescence in melanoma cells. As our immunoflu-
orescence procedures detect DNA dsb (Fig 3), the most
reasonable explanation for finding higher numbers of
gH2AX foci in melanoma cells is that there are higher num-
bers of DNA dsb in these cells. The presence of increased
numbers of DNA dsb in melanoma cells is supported by the
co-localization of the gH2AX foci in untreated melanoma
cells with DNA dsb-associated proteins such as the ATM,
BRCA1, 53BP1, and Nbs1 proteins (Fig 4) and the signif-
icant increase in the number of micronuclei that form in
these cells (Table I). A molecular explanation for why there
would be increases in DNA dsb in melanoma cells is not
clear. One obvious possibility is that some environmental
agent induces more DNA dsb in the melanoma cells than in
MC. As all cells were cultured side by side, this possibility
seems unlikely. Another possibility is that a nuclear end-
onuclease is more active in melanoma cells than in MC.
In preliminary experiments in which nuclei from MC or
YUSAC2 cells were isolated, placed into an endonuclease
friendly buffer and incubated at 37oC for increasing times,
nuclear DNA was cut to small fragments faster in YUSAC2
cells than in MC. Thus, YUSAC2 cells may either have more,
or more active, nuclear endonucleases than MC; however,
because nuclear endonuclease activities are likely under
strict control, the involvement of altered nuclear endonuc-
lease activity in the few DNA dsb observed in melanoma
cells seems unlikely.
An alternate explanation for the increased numbers of
gH2AX foci in melanoma cells might be that histone H2AX
adjacent to a nuclear alteration other than a DNA dsb is
being recognized by either the ATM or DNA PK proteins in
untreated melanoma cells. Consistent with this possibility,
we found that the number of gH2AX foci remaining in YU-
SAC2 cells 12 h after irradiation is the same as the number
of foci that existed prior to irradiation (Fig 3). If the DNA
changes that result in pre-existing gH2AX foci in YUSAC2
cells were structurally the same as those produced by IR,
the DNA dsb repair processes that act of IR-induced
dsb should reduce the number of these DNA changes, and
thus gH2AX foci, to the level observed in MC 12 h after
irradiation. As this did not happen, our results indicate
that the repair process involved in rejoining IR-induced dsb
is not involved directly in repairing the DNA damage
that pre-existed irradiation. Thus, the gH2AX foci pre-exist-
ing in untreated melanoma cells must detect DNA altera-
tions that are structurally different from the DNA dsb
induced by IR.
Nuclear changes that might have characteristics similar
to the ones that produce gH2AX foci in untreated melanoma
cells are dysfunctional replication or maintenance of telo-
meres. Co-localization of a majority of gH2AX foci in un-
treated melanoma cells with the TRF1 protein suggests that
the DNA change being detected by PIKK is associated with
telomeres. Telomeres are specialized structures at the ends
of linear chromosomes that protect genomic DNA from
degradation. Failure to maintain proper telomere length or
structure can result in chromosome rearrangements, cell
apoptosis, senescence, or permanent inhibition of cell pro-
liferation (Lee et al, 1998; Chin et al, 1999; Karlseder et al,
1999; Smogorzewska and de Lange, 2002). Cancer cells
maintain telomere length either by activation of telomerase
or by an alternate lengthening of telomeres (ALT) mecha-
nism. Telomeres involved in the ALT replication mechanism
co-localize with the BRCA1 protein and the Mre11/Nbs1/
Rad50 repair complex (Wu et al, 2003). As BRCA1 and Nbs1
proteins co-localize with gH2AX foci in untreated melanoma
cells, it is possible that we are detecting telomeres involved
in ALT. The majority of melanomas, however, have sufficient
telomerase activity to maintain telomere length (Glaessl
et al, 1999; Parris et al, 1999). Thus, it is more likely that the
gH2AX foci detected at untreated melanoma cells are at
telomeres that are experiencing routine maintenance prob-
lems. This speculation is consistent with our observation
that the gH2AX foci observed in melanoma cells occur
throughout the cell cycle (Fig 5), not primarily during the S
phase when telomere replication would be expected. Fail-
ure to properly maintain telomere ends can result in un-
capped telomeres that activate PIKK such as the ATM
protein (Takai et al, 2003). Uncapped telomeres are asso-
ciated with foci of DNA dsb repair proteins such as the
phosphorylated ATM and 53BP1 proteins, Mre11 and
gH2AX proteins (Takai et al, 2003). Consistent with this
possibility, we found that a majority of gH2AX foci both in
untreated primary and melanoma cells co-localize with the
TRF1 protein, as well as with phosphorylated ATM and
53BP1 proteins and the Nbs1 protein (Fig 4). Uncapped
telomeres may persist in tumor cells and induce a DNA dsb
stress response in cells before and after cells are irradiated.
Thus, the gH2AX foci that we observe in untreated me-
lanoma cells may be induced by uncapped telomeres.
Thus, we speculate that the excess gH2AX foci observed
in melanoma cells decorate dysfunctional telomeres. In
normal cells with functional stress response pathways, un-
capped or dysfunctional telomeres are detected by PIKK
that signal through stress response pathways such as the
p53 DNA damage response pathway, and induce perma-
nent cell growth arrest, senescence or cell death (Lee et al,
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1998; Chin et al, 1999; Karlseder et al, 1999; Smogorzewska
and de Lange, 2002). Thus, we would expect cells contain-
ing aberrant telomeres to be eliminated from the cell pop-
ulation. In primary MC, abnormal telomeres are detected by
functional PIKK (Fig 3) that activate functional down-stream
stress response pathways such as the p53 pathway (Fig 7).
Activation of these stress responses in MC must eliminate
cells containing aberrant telomeres as there is no accumu-
lation of gH2AX foci or chromosome damage in normal MC.
In contrast, the frequency of gH2AX foci remains high in
melanoma cells. Melanoma cells detect DNA damage as
efficiently as MC (Fig 3), but cannot launch a fully functional
DNA damage stress response (Fig 7). In consequence, cells
containing aberrant telomeres are not as effectively elimi-
nated from melanoma populations, ultimately leading to
higher levels of chromosome rearrangements such as
micronuclei.
A final question is whether the increased DNA strand
breaks in melanoma cells lead to chromosome structural
instabilities such as increased numbers of micronuclei.
Whereas melanoma cells close IR-induced DNA dsb as
rapidly and thoroughly as do MC, they do not repair those
strand breaks that existed prior to IR exposure (Fig 3).
These pre-existing strand breaks apparently persist during
mitosis and may lead to the high number of micronuclei
observed in binucleate melanoma cells (Table I). Cells from
patients with DNA dsb repair recognition and repair disor-
ders, such as ataxia telangiectasia, are known to express
high levels of chromosome instability. Failure of PIKK such
as the ATM protein to function as DNA dsb sensors is not
involved in micronucleus formation in these melanomas
because PIKK function normally in MC and all four me-
lanomas, and phosphorylate the H2AX histone in response
to IR exposure (Table I). In contrast, stress signaling from
the ATM protein sensor through the p53 damage response
pathway into activation of the CDKN1A gene is largely non-
functional in the melanomas (Fig 7 and Table II), presumably
because of mutations in the p53 protein. Only in the LOX
melanoma does IR induce CDKN1A activation (Table II).
Thus, it is possible that the failure of the p53 protein to
function either to induce cell cycle blocks or to induce
apoptosis, both mechanisms through which cells containing
genome damage are removed from the cell population, may
be intimately involved in the failure of the melanoma cells to
close all DNA dsb.
We conclude that higher numbers of DNA dsb, or chro-
matin alterations interpreted as DNA strand breaks, are
present in interphase melanoma cells than in primary MC.
These DNA alterations are detected by PIKK such as the
ATM protein, which phosphorylate adjacent H2AX histones
producing gH2AX foci. The most likely mechanism for the
increased gH2AX foci is that the maintenance or capping of
chromosome telomeres is dysfunctional in melanoma cells.
Failure to correctly maintain telomeres may result in rear-
rangements of chromosomal DNA and the production of
chromosome rearrangements such as micronuclei.
Materials and Methods
Antibodies A mouse monoclonal antibody against the p53 protein
(cat # OP43), a rabbit polyclonal antibody against Nbs1 (cat #
PC269), and a mouse monoclonal antibody against BRCA1 (cat #
OP92) were purchased from Oncogene (Boston, Massachusetts).
A mouse monoclonal antibody against CDKN1A p21/Waf1 (cat # sc-
817), a goat polyclonal antibody against human actin (cat # sc-
1616) and a goat polyclonal antibody against TRF1 protein (cat #
sc-1977) were purchased from Santa Cruz Biotechnology (Santa
Cruz, California). A mouse monoclonal antibody (cat # 05–636) and
a rabbit polyclonal antibody (cat # 07–164) against H2AX histone
phosphorylated on serine 139 (gH2AX) were purchased from Up-
state Biotechnology (Charlottesville, Virginia). A rabbit polyclonal
antibody against TP53 phosphoserine 15 (cat # 9284) was pur-
chased from Cell Signaling Technology (Beverly, Massachusetts). A
rabbit polyclonal antibody against 53BP1 protein was provided by
Dr Phillip B. Carpenter, Department of Biochemistry and Molecular
Biology, University of Texas Health Sciences Center, Houston,
Texas. A mouse monoclonal antibody against ATM phosphoserine
1981 (cat # 200–301–400) was purchased from Rockland Immuno-
chemicals (Bilbertsville, Pennsylvania).
Tissue collection, preparation of primary skin cells, and cell
treatment Discarded human neonatal foreskins were collected in
accordance with the University of Utah’s Institutional Review Board
Policies from the LDS Hospital in Salt Lake City, Utah (IRB#9476–
01). The tissue was collected at room temperature in 1X Ham’s F12
medium (Gibco, Carlsbad, California) supplemented with antibiot-
ic–antimycotic solution (Gibco-BRL 15240–039). The skin was
trimmed of excess fat and connective tissue, rinsed several times
with phosphate-buffered saline (PBS), and dissected into approx-
imately 3.5 mm2 sections. Primary cells were isolated from these
skin sections as described elsewhere (Bowen et al, 2003). Neo-
natal human MC were cultured in Hams F12 medium supplement-
ed with 7.5% calf serum, 1% glutamine, 100 mM 3-isobutyl-1-
methylxanthine, 200 mg per L cholera toxin, 1 mM sodium ortho-
vanadate, and 0.08 mM phorbol 12-myristate 13-acetate. MC were
cultured at 371C in a 5% CO2 environment and were used between
passages 1 and 5. All melanoma cell lines and HaCaT cells were
obtained from Dr D. Grossman (University of Utah, Huntsman
Cancer Institute, Salt Lake City, Utah). HeLa cells were obtained
from the American Type Culture Collection. All cancer cell lines
were cultured in F12 medium supplemented with 10% fetal bovine
serum (FBS). All melanoma cell lines are from metastatic me-
lanomas. The LOX cell line (Fodstad et al, 1988) is from an am-
elanotic axilliary lymph-node metastasis that developed in a 58-y-
old Caucasian male, the YUGEN8 is from the left frontal brain, and
the YUSAC2 is from the left neck, whereas the exact metastatic
location of the YUSIT1 melanoma is unknown (Dr R. Halaban,
personal communication). HeLa cells were originally isolated from
a cervical adenocarcinoma and the HaCaT cells from a cutaneous
squamous cell carcinoma. Cells were irradiated in whole medium
with g rays using the Shephard Mark I 137Cs Irradiator (J. L.
Shepherd & Associates, San Fernando, California) at a dose rate of
4.7 Gy per min at the Huntsman Cancer Institute’s Irradiation Fa-
cility. Cells were replaced into a 371C incubator immediately after
irradiation and collected at appropriate post-treatment times, as
indicated.
FCM analyses FCM analysis of DNA distributions was performed
with a Facscan 1 Flow Cytometer (Becton Dickenson, San Jose,
California) on cells that had been fixed in 70% ethanol, as previ-
ously described (Warters, 1992). Flow cytometry results were
analyzed with ModFit 1 software. The DI was calculated as the
ratio of the G1 DNA content in cancer cells over the G1 DNA con-
tent of MC. Flow cytometry analysis of gH2AX expression through-
out the cell cycle was performed as previously described
(MacPhail et al, 2003). In brief, cells previously fixed with 70%
ethanol were rehydrated in Tris-buffered saline (TBS) containing
4% FBS and 0.1% Triton  100, exposed to a 1/500 dilution of a
monoclonal antibody against gH2AX, washed free of primary an-
tibody, exposed to a 1/200 dilution of an Alexa 488-conjugated,
anti-mouse secondary antibody, washed free of secondary
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antibody, stained with propidium iodide, and analyzed with the
Facscan 1 Flow Cytometer for both the amount of DNA and gH2AX
fluorescence signal per cell. A negative control group (i.e., cells
exposed to a nonspecific mouse immunoglobulin G1) was run
alongside each anti-gH2AX monoclonal antibody exposed group.
Immunoﬂuorescence microscopy Cells were plated onto 35
mm2 plastic dishes. Cells were washed with PBS and fixed either
with 2% paraformaldehyde in PBS for 7 min or with 100% meth-
anol for 10 min at 201C. The cells were rinsed to remove fixative,
permeabilized with Triton X-100, and rinsed with PBS. The cells
were exposed to a blocking solution of either 0.1% bovine serum
albumin (BSA) (for monoclonal gH2AX and 53BP1), 10% calf serum
(for Nbs1 and BRCA1), or 5% donkey serum (for TRF1). Primary
antibody was diluted (1:500 for gH2AX, 1:300 for 53BP1, 1:150 for
BRCA1, and 1:100 for polyclonal gH2AX, Nbs1 and TRF1) in either
PBS or 0.1% BSA in PBS and exposed to the cells for 1 h at room
temperature or for 30 min at 371C for 53BP1. Cells were rinsed with
PBS for 5 min, three times before being exposed to Alexa 488 and/
or Alexa 568 (Molecular Probes, Eugene, Oregon)-conjugated anti-
mouse, anti-goat, or anti-rabbit secondary antibody. The cells were
exposed to 0.7 mM diamidinophenyl indole (DAPI), a nuclear DNA
stain. The cells were washed three times with PBS for 5 min each
and mounted with Fluorsave (Calbiochem, La Jolla, California) an-
tifade mounting solution. Cells were visualized using an Olympus
Provus microscope (Olympus America Inc., Melville, New York)
using a 100  objective. Images were captured using Axiovision
software. Forty to 150 cells were counted per point.
Micronucleus assay Quantification of micronuclei was performed
similar to previous reports (Fenech and Morley, 1986; Gutierrez-
Enriquez and Hall, 2003). Cells were cultured on 35 mm2 dishes,
incubated in 3 mg per mL Cytochalasin B for 48 h, rinsed with PBS,
fixed with 100% methanol at 201C, and air-dried. Cells were re-
hydrolyzed with PBS, stained with 0.7 mM DAPI, mounted onto
slides with Fluorsave, allowed to dry, and then stored at 201C
until counted. Micronuclei were counted if they had roughly the
same fluorescence intensity as nuclei and were clearly distinguish-
able as nonnuclear particles. Binucleated cells were defined using
the bright field, white light. At least 1000 binucleated cells were
counted on an Olympus Provus microscope using a  60 ob-
jective. Approximately 40% of MC and 60% of melanoma cells
were observed as binucleated cells after 48 h of Cytochalasin B
treatment.
Cell protein analysis by western blotting Cell protein was re-
covered by scraping cells into a RIPA buffer (50 mM Hepes, 150
mM NaCl, 5 mM EDTA, 1 mM EGTA, 1 mM NaF, 15 mM p-nitro-
phenyl phosphate, disodium hexahydrate, 2 mM NaVO4, 1 mM
DTT, 2 mM PMSF, 1% NP-40, 0.1% SDS, 1% Triton X-100, 1%
deoxycholate, and a 1:400 dilution of a Protease inhibitor cocktail)
(Sigma cat# P1860, St. Louis, Missouri)). Protein content was de-
termined using a Bradford colorimetric reaction (BioRad, Hercules,
California). Protein samples were electrophoresed through SDS,
4%–12% polyacrylamide gradient gels (InVitrogen, Carlsbad,
California) in 2-(N-morpholino) ethane sulfonic acid/Tris-SDS run-
ning buffers at 150 V, and electrotransferred onto a polyvinylidene
fluoride (PVDF) membrane at 220 mA at 41C. Protein epitopes
transferred to the PVDF membranes were detected using primary
antibodies dissolved in TBS containing 0.1% Tween 20 and 5%
non-fat dried milk. Primary antibodies were identified using a
horseradish peroxidase-labeled secondary antibody and by expo-
sure to Amersham Hyperfilm ECL photographic film using Amer-
sham ECL (or ECL Plus) (Amersham Biosciences, Piscataway, New
Jersey) chemiluminescence reagents according to the manufac-
turer’s recommendations. Exposed films were quantified using a
BioRad Model GS-700 Imaging Densitometer. Density units for
each photographic negative band were corrected for variations in
loading using the actin band as the reference and normalized
against the unirradiated control lane.
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